Company Data
Kazia Therapeutics Limited
Ticker
KZIA
Current Price
$9.96 -22.13%
Market Cap
$16.6M
Price Target
Refer to Report
Volume
406.1K
52wk Range
$2.86 - $145
Overview
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing GDC-0084, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others.